Therapeutic agent for sepsis
CA 2451133 C · Owner: Yoshizawa, Yoshitaka · Inventors: Inada, Hideaki; Suzuki, Tomohiko; Tanaka, Toshiaki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A therapeutic agent for sepsis and various symptoms accompanying sepsis (such as septic shock, disseminated intravascular coagulation syndrome adult , respiratory , distress syndrome and multiple organ dysfunction) is disclosed. The therapeutic agent , for sepsis according to the present invention comprises as an effective ingredient an , opioid .kappa. receptor agonist compound such as (-)-17-(cyclopropylmethyl)- 3,14.beta.-, dihydroxy-4,5.alpha.-epoxy-6.beta.N-methyl-trans-3-(3-furyl)acrylamido morphinan derivative. , The opioid .kappa. receptor agonist compound may be administered as it is or in the form of a , pharmaceutical composition prepared by mixing the compound with a known …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 8, 2002 and granted September 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 8, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 8, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.